Imvaq Therapeutics Competitors and Similar CompaniesClear all

Imvaq Therapeutics's competitors and similar companies include Prosetta, AC Immune, Umoja Biopharma and Astria Therapeutics.

	Imvaq Therapeutics Imvaq Therapeutics is a company that develops cancer immunotherapy solutions.	Prosetta Prosetta Corporation operates as a biopharmaceutical company in the United States.	AC Immune AC Immune is a biopharmaceutical company developing therapeutics against Alzheimer´s disease and other conformational diseases.	Umoja Biopharma Umoja Biopharma is a company engaged in immunotherapies discovery.	Astria Therapeutics Astria Therapeutics (formerly known as Catabasis Pharmaceuticals) discovers and develops innovative drugs for treating inflammatory conditions.
Founding Date	Founding Date 2016	Founding Date N/A	Founding Date 2003	Founding Date 2019	Founding Date 2008
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare drug development pharma platform	Tags Healthcare biotech drug development pharma platform	Tags Healthcare biotech drug development pharma platform	Tags Healthcare biotech drug development pharma platform	Tags Healthcare drug development pharma platform
Locations	Locations Sammamish, US HQ	Locations San Francisco, US HQ	Locations Lausanne, CH HQ	Locations Seattle, US HQ Seattle, US	Locations Boston, US HQ
Employees	Employees 2	Employees 254% increase	Employees 133	Employees 1951% increase	Employees 2433% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 297.8 m	Valuation ($) N/A	Valuation ($) 683.3 m
Financial
Net income	Net income N/A	Net income N/A	Net income (CHF50.9m) (FY, 2024)	Net income N/A	Net income ($94.3m) (FY, 2024)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 2m (about 19 years ago)	Latest funding round N/A	Latest funding round $ 210m (almost 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 2m	Total funding raised $ 117.4m	Total funding raised $ 263m	Total funding raised $ 94.9m